Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression.

Abstract

Carcinogenesis is a multistep process by which normal cells acquire genetic and epigenetic changes that result in cancer. In combination with host genetic susceptibility and environmental exposures, a prominent procarcinogenic role for the microbiota has recently emerged. In colorectal cancer (CRC), three nefarious microbes have been consistently linked to cancer development: (<i>a</i>) Colibactin-producing <i>Escherichia coli</i> initiates carcinogenic DNA damage, (<i>b</i>) enterotoxigenic <i>Bacteroides fragilis</i> promotes tumorigenesis via toxin-induced cell proliferation and tumor-promoting inflammation, and (<i>c</i>) <i>Fusobacterium nucleatum</i> enhances CRC progression through two adhesins, Fap2 and FadA, that promote proliferation and antitumor immune evasion and may contribute to metastases. Herein, we use these three prominent microbes to discuss the experimental evidence linking microbial activities to carcinogenesis and the specific mechanisms driving this stepwise process. Precisely defining mechanisms by which the microbiota impacts carcinogenesis at each stage is essential for developing microbiota-targeted strategies for the diagnosis, prognosis, and treatment of cancer.